Antibiotic CAS 21736-83-4 Spectinomycin Hydrochloride Veterinary Grade Spectinomycin Powder Hydrochloride Spectinomycin HCl

China Antibiotic CAS 21736-83-4 Spectinomycin Hydrochloride Veterinary Grade Spectinomycin Powder Hydrochloride Spectinomycin HCl, Find details about China Spectinomycin, Spectinomycin HCl from Antibiotic CAS 21736-83-4 Spectinomycin Hydrochloride Veterinary Grade Spectinomycin Powder Hydrochloride Spectinomycin HCl

Basic Info.

Model NO.

D-Sung Spectinomycin Hydrochloride

Name

Spectinomycin Hydrochloride Powder

Appearance

White Powder

Color

White

Store

Cool and Dry

Grade

Pharmaceutical Grade Veterinary Grade

Assay

HPLC 99%

Application

Anthelmintics

Specific

COA

Test Method

HPLC

Shelf Life

2 Years

CAS No.

21736-83-4

Molecular Formual

C14h26cl2n2o7

Density

1.43

Melting Point

1.94

Trademark

D-Sung

Transport Package

Negotiable

Specification

99%

Origin

Xi′an Shaanxi

Model NO.

D-Sung Spectinomycin Hydrochloride

Name

Spectinomycin Hydrochloride Powder

Appearance

White Powder

Color

White

Store

Cool and Dry

Grade

Pharmaceutical Grade Veterinary Grade

Assay

HPLC 99%

Application

Anthelmintics

Specific

COA

Test Method

HPLC

Shelf Life

2 Years

CAS No.

21736-83-4

Molecular Formual

C14h26cl2n2o7

Density

1.43

Melting Point

1.94

Trademark

D-Sung

Transport Package

Negotiable

Specification

99%

Origin

Xi′an Shaanxi

Product Desciption

Antibiotic CAS 21736-83-4 Spectinomycin Hydrochloride Veterinary Grade Spectinomycin Powder Hydrochloride Spectinomycin HCl

Name	SPECTINOMYCIN DIHYDROCHLORIDE
C.A.S NO.	21736-83-4
Molecular formula	C14H26Cl2N2O7
Molecular weight	405.27
Melting point	194°C

An antibiotic used in the treatment and control of infectious bacterial enteritis in animals. Used in drug testing against nonreplicating mycobacterium tuberculosis.

Spectinomycin dihydrochloride pentahydrate is an aminocylcitol antibiotic which is closely related to the aminoglycosides.Gram-positive and gram-negative Gonococcus spp. are reported to exhibit susceptibility to Spectinomycin. Studies indicate thatSpectinomycin interferes with peptidyl tRNA translocation thereby affecting protein synthesis in susceptible bacteria. Additional reports note that mutations in ribosomal proteins may prevent the binding of spectinomycin, thus potentially confering resistence to the compound. Additionally, Eschericia coli is reported to be reversibly inhibited during growth and division by Spectinomycin and that variations in bacterial sensitivity may be mediated by differences in ribosomes among different E. coli mutants.